PHVS.NASDAQPharvaris NV

SCHEDULE: Pharvaris N.V. Shareholding Update by LSP V

Sentiment:

Beneficial Ownership Filing


LSP V Cooperatieve U.A. and LSP V Management B.V. report a 4.9% stake in Pharvaris N.V. as of June 30, 2026.

Summary

  • LSP V Cooperatieve U.A. and LSP V Management B.V. have filed a Schedule 13G, indicating their beneficial ownership of Pharvaris N.V. ordinary shares.
  • As of June 30, 2026, the reporting persons collectively beneficially own 3,424,609 ordinary shares.
  • This holding represents 4.9% of the total outstanding ordinary shares of Pharvaris N.V.
  • The outstanding share count of 69,666,453 is based on information from Pharvaris N.V.'s prospectus and Form 6-K filed in May 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of shareholding and does not contain operational or financial performance updates.

Positives

  • LSP V Cooperatieve U.A. holds a significant stake of 4.9% in Pharvaris N.V., indicating investor confidence.
  • The filing is an amendment to a Schedule 13G, suggesting ongoing monitoring and reporting of shareholdings.

Negatives

  • The reporting persons have no sole voting or dispositive power, with all ownership being shared.
  • The filing does not provide details on the investment strategy or rationale behind the shareholding.

Risks

  • Market volatility could impact the value of the 3,424,609 ordinary shares held.
  • Changes in Pharvaris N.V.'s business performance or strategic direction could affect the investment.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Pharvaris N.V. It solely reports the shareholding of LSP V.

Management Comments

  • LSP V Cooperatieve U.A. and LSP V Management B.V. are the reporting persons.
  • Martijn Kleijwegt, Rene Kuijten, and Joachim Rothe are the managing directors of LSP V Management B.V.
  • The managing directors disclaim beneficial ownership of the shares held by LSP V.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by LSP V indicates a significant institutional investor's position in Pharvaris N.V., a biotechnology company. Such filings are common for venture capital and private equity firms as they approach or cross ownership thresholds, often signaling active interest or a strategic investment.

Stakeholder Impact

  • Shareholders: The filing provides transparency on a significant institutional investor's stake, which can influence market perception.
  • Management of Pharvaris N.V.: Awareness of LSP V's ownership level is important for strategic planning and investor relations.

Next Steps

  • Continued monitoring of Pharvaris N.V.'s share price and corporate actions by LSP V.
  • Potential future filings by LSP V if their ownership stake changes significantly.

Key Dates

DateDescription
05/08/2026Pharvaris N.V. filed prospectus on Form 424B5.
05/11/2026Pharvaris N.V. filed Form 6-K and closed an underwritten offering.
06/30/2026Date of event requiring filing of this statement; ownership as of this date.
07/31/2026Date of certification and signatures on the Schedule 13G filing.

Keywords

Pharvaris N.V., LSP V Cooperatieve U.A., LSP V Management B.V., Schedule 13G, Shareholding, Beneficial Ownership, Ordinary Shares, Investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.